Effectiveness, Tolerability, Safety of Rasagiline in Early Parkinson's Disease Patients Without Levodopa

- Parkinson's Disease
- Completed

Study Title: Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa

Teva Identifier: TVP-1012/232

ClinicalTrials.gov Identifier: NCT00203060

Study Status: Completed

Trial Condition(s): Parkinson's Disease

Interventions: Drug: Rasagiline Mesylate | Drug: placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 35 Years and older

Trial Duration: 07/01/1997 - 07/01/2000

Phase: Phase 3

Study Type

Interventional